Long-Term Outcome of Pediatric Patients with Severe Aplastic Anemia Treated with Antithymocyte Globulin and Cyclosporine
- 31 July 2008
- journal article
- research article
- Published by Elsevier BV in The Journal of Pediatrics
- Vol. 153 (6), 814-819.e1
- https://doi.org/10.1016/j.jpeds.2008.06.004
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Comparable Outcomes of Matched-Related and Alternative Donor Stem Cell Transplantation for Pediatric Severe Aplastic AnemiaTransplantation and Cellular Therapy, 2006
- Current concepts in the pathophysiology and treatment of aplastic anemiaBlood, 2006
- Treatment of severe aplastic anaemia with combined immunosuppression: anti‐thymocyte globulin, ciclosporin and mycophenolate mofetilBritish Journal of Haematology, 2006
- Optimization of conditioning for marrow transplantation from unrelated donors for patients with aplastic anemia after failure of immunosuppressive therapyPublished by American Society of Hematology ,2006
- Immunosuppressive therapy for aplastic anemia in children: a more severe disease predicts better survivalBlood, 2005
- Mutations inTERT,the Gene for Telomerase Reverse Transcriptase, in Aplastic AnemiaNew England Journal of Medicine, 2005
- Late presentation of dyskeratosis congenita as apparently acquired aplastic anaemia due to mutations in telomerase RNAThe Lancet, 2003
- Current status of allogeneic bone marrow transplantation in acquired aplastic anemiaSeminars in Hematology, 2000
- Relapse and clonal disease in children with aplastic anemia (AA) after immunosuppressive therapy (IST): the SAA 94 experienceKlinische Padiatrie, 1998
- Comparison between bone marrow transplantation and antithymocyte globulin in treatment of young patients with severe aplastic anemiaThe Journal of Pediatrics, 1984